-
April 4: The Week in Cancer NewsSome early-stage breast cancer patients may not need surgery, and FDA approves Imfinzi for muscle-invasive bladder cancer.
by Eric Fitzsimmons
-
March 28: The Week in Cancer NewsNew prostate cancer surgery approach can prevent sexual side effects, and some people with esophageal cancer may be able to avoid surgery.
by Thomas Celona
-
March 21: The Week in Cancer NewsCooling and compression help manage common side effect of chemotherapy, and deadlines encourage people to complete colorectal cancer screening.
by Marci A. Landsmann
-
March 14: The Week in Cancer NewsPickleball encourages more activity in cancer survivors, and urine test detects aggressive prostate cancer.
by Kevin McLaughlin
-
March 7: The Week in Cancer NewsHPV vaccine credited for 80% drop in lesions that can lead to cervical cancer, and FDA approves targeted therapy for esophageal cancer.
by Thomas Celona
-
February 28: The Week in Cancer NewsExercise associated with increased survival after colon cancer, and screening costs remain a hurdle for women with dense breasts.
by Eric Fitzsimmons
-
February 21: The Week in Cancer NewsMen with metastatic prostate cancer urged to ask questions about care, and early-phase study suggests benefit of pancreatic cancer vaccine.
by Marci A. Landsmann
-
February 14: The Week in Cancer NewsPesticide firms try to block cancer-related lawsuits, and cancer pain leads to greater tobacco and cannabis use.
by Kevin McLaughlin
-
February 7: The Week in Cancer NewsResearchers explore musical toxicity from cancer treatment, and kidney cancer vaccine shows potential in early trial.
by Eric Fitzsimmons
-
January 31: The Week in Cancer NewsFDA approves an antibody-drug conjugate for people with HER2-ultralow breast cancer, and historic redlining practices have a lingering impact on cancer outcomes.
by Thomas Celona
Adding chemotherapy to targeted therapy improves outcomes for people with advanced EGFR-positive non-small cell lung cancer.
by Sandra Gordon
Lessons From 20 Years Living With CancerMultiple myeloma survivor Jonathan Gluck reflects on uncertainty, and the scientific progress that has kept him living with cancer for more than two decades.
by Eric Fitzsimmons
The Enduring Importance of Cancer Disparities ResearchOpening session from AACR conference highlights how perseverance and adversity have informed cancer disparities research over the years.
by Eric Fitzsimmons
Most Cancer Survivors Don’t Meet Healthy Diet GoalsDespite research linking fruits and vegetables to cancer survival, many people do not change their eating habits after diagnosis.
by Darlene Dobkowski
-
Keeping Hope Alive—Why the Schlueters Rally for Medical ResearchRichard and Michelle Schlueter attended the Rally for Medical Research to advocate for NIH funding after budget cuts delayed his treatment.
-
Cancer in the Rearview Mirror: 15 Years of AACR Cancer Progress Report Survivor StoriesCancer survivors profiled over the past 15 years in the AACR Cancer Progress Reports shared updates on their lives and the progress made against cancer.
Cancer Research at a Crossroads
